Articles dans des revues avec comité de lecture (40)
  1. 11. Koubaity, M., Lelubre, M., Sansterre, G., Amighi, K., & De Vriese, C. (2019). Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies. International Journal of Clinical Pharmacy, 41(1), 244-250. doi:10.1007/s11096-018-0773-y
  2. 12. Foubert, K., Mehuys, E., Maesschalck, J., De Wulf, I., Wuyts, J., Foulon, V., Lelubre, M., De Vriese, C., Somers, A., Petrovic, M., & Boussery, K. (2019). Pharmacist-led medication review in community-dwelling older patients using the GheOP3S-tool: General practitioners' acceptance and implementation of pharmacists' recommendations. Journal of evaluation in clinical practice. doi:10.1111/jep.13241
  3. 13. Lelubre, M., Clerc, O., Grosjean, M., Amighi, K., De Vriese, C., Bugnon, O., & Schneider, M. P. (2018). Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results. BMC health services research, 18, 874. doi:10.1186/s12913-018-3641-5
  4. 14. Lelubre, M., Wuyts, J., Maesschalck, J., Duquet [EXT], N., Foubert, K., Hutsebaut, C., Moullin, J., De Wulf [EXT], I., Boussery, K., Foulon, V., & De Vriese, C. (2018). Implementation study of an intermediate medication review in Belgian community pharmacies. Research in Social and Administrative Pharmacy.
  5. 15. Lelubre, M., Clerc, O., Grosjean, M., Amighi, K., De Vriese, C., Bugnon, O., & Schneider, M. P. (2018). Implementation of an interprofessional medication adherence program for HIV patients: description of the process using the framework for the implementation of services in pharmacy. BMC health services research, 18, 698. doi:10.1186/s12913-018-3509-8
  6. 16. Lelubre, M., Hamdani, J., Senterre, C., Amighi, K., Peres, M., Schneider, M. P., Bugnon, O., & De Vriese, C. (2018). Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium. Pharmacoepidemiology and drug safety, 27(6), 668-673. doi:10.1002/pds.4441
  7. 17. Biset, N., Lelubre, M., Senterre, C., Amighi, K., Bugnon, O., Schneider, M. P., & De Vriese, C. (2018). Assessment of medication adherence and responsible use of isotretinoin and contraception through belgian community pharmacies by using pharmacy refill data. Patient Preference and Adherence, 12, 153-161. doi:10.2147/PPA.S149355
  8. 18. Berger, J., Bawab, N., De Mooij, J., Sutter Widmer, D., Szilas, N., De Vriese, C., & Bugnon, O. (2018). An open randomized controlled study comparing an online text-based scenario and a serious game by Belgian and Swiss pharmacy students. Currents in pharmacy teaching & learning, 10(3), 267-276. doi:10.1016/j.cptl.2017.11.002
  9. 19. Salade, L., Wauthoz, N., Deleu, M., Vermeersch, M., De Vriese, C., Amighi, K., & Goole, J. (2017). Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia. International Journal of Nanomedicine (Online), 12, 8531—8543. doi:10.2147/IJN.S147650
  10. 20. Fraeyman, J., Naegels, M., De Meyer, G. R., De Loof, H., Van Hal, G., Van den Broucke, S., Foulon, V., Mehuys, E., Boussery, K., Saevels, J., De Vriese, C., Dalleur, O., Housiaux, M., & Steurbaut, S. (2017). Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium. Research in Social and Administrative Pharmacy, 13(1), 98-108. doi:10.1016/j.sapharm.2016.02.001
  11. 21. Lelubre, M., Koubaity, M., De Wulf [EXT], I., Boussery, K., De Meyer, G. R., Foulon, V., Lacour, V., Steurbaut, S., Van Hees, T., Amighi, K., Bugnon, O., & De Vriese, C. (2016). Fréquence et nature des problems liés aux corticosteroïdes dans les officines publiques de Belgique. Journal de pharmacie de Belgique,(3), 32-41.
  12. 22. Reeff, J., Oprenyeszk, F., Franck, T., Goole, J., De Vriese, C., Serteyn, D., Henrotin, Y., & Amighi, K. (2015). Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis. International journal of pharmaceutics, 490(1-2), 14855, 74-84. doi:10.1016/j.ijpharm.2015.04.064
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>